Image 1 of 1
Image 1 of 1
Image 1 of 1
Image 1 of 1
Retatrutide is a novel investigational peptide currently under study as a triple receptor agonist, targeting GLP-1, GIP, and glucagon receptors. Preclinical and early clinical research has focused on its potential impact on metabolic regulation, including pathways related to energy balance, insulin sensitivity, and body weight management. Scientific interest continues to grow regarding its comparative activity to other GLP-1–based compounds in research models. For Research Use Only. Not intended for human consumption, medical, diagnostic, or therapeutic purposes.
Retatrutide is a novel investigational peptide currently under study as a triple receptor agonist, targeting GLP-1, GIP, and glucagon receptors. Preclinical and early clinical research has focused on its potential impact on metabolic regulation, including pathways related to energy balance, insulin sensitivity, and body weight management. Scientific interest continues to grow regarding its comparative activity to other GLP-1–based compounds in research models. For Research Use Only. Not intended for human consumption, medical, diagnostic, or therapeutic purposes.
